Amukine

Quick links to important sections

Amukine

Selected form

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Amukine

Property Description
Active ingredient Sodium Hypochlorite
Form Topical Solution
Pharmacological class Antiseptic and Disinfectant
General Purpose Local infection prevention
Origin Synthetic chemical compound

What Type of Solution is Amukine?

Amukine is a specialized, single-active-ingredient pharmaceutical preparation primarily recognized in the European market, classified as a topical solution within the Pharmacological class of antiseptics and germicides. It is intended exclusively for topical administration onto the skin and mucous membranes. The solution is formulated to be non-irritating at its medicinal concentration, a distinctive feature intended for direct skin application. The fluid dosage form is designed to provide comprehensive, immediate coverage for effective local infection prevention, distinguishing its external application from oral or systemic medicines.

The Active Ingredient: Sodium Hypochlorite Composition

The foundational active ingredient of Amukine is Sodium Hypochlorite (INN), a synthetic chemical compound which is recognized for its disinfecting properties. In this pharmaceutical context, the Sodium Hypochlorite is presented in a specific, stabilized, and highly diluted concentration within an aqueous base, unlike stronger industrial variants. The formulation ensures that its antimicrobial effect is attributable entirely to the hypochlorite compound, which provides a means for the rapid destruction of pathogens. This preparation adheres to standards for chemical disinfection efficacy, a requirement for external agents used in healthcare settings.

General Purpose and Core Antimicrobial Action

The general purpose of Amukine is to provide rapid and effective skin and mucosa disinfection by chemically neutralizing pathogenic microorganisms, thereby reducing the microbial load at the application site. The solution accomplishes this through a broad-spectrum chemical process, primarily oxidation, which physically disrupts the cellular structures of bacteria, fungi, and viruses. This potent chemical action is the core functional benefit, ensuring the treated surface is clean and prepared for natural healing processes. The solution is commonly used to support hygiene and prevent localized issues arising from minor superficial cuts or scrapes.

What side effects are possible with Amukine?

Possible Side Effects and Safety Information

This section describes the officially documented adverse reactions and safety characteristics for Sodium Hypochlorite Topical Solution (Amukine), strictly based on governmental regulatory sources. The safety profile is defined predominantly by local reactions at the site of application.


Adverse Reaction Scope

Category Details
Key Adverse Reactions Reactions are primarily localized to the application site.
System-Organ Class Effects are generally categorized under Skin and subcutaneous tissue disorders.
Common Documented Effects Officially documented adverse reactions include local irritation, a burning sensation, and local pain.
Serious Adverse Reactions While no separate category for “Serious Adverse Reactions” is defined in the main regulatory documents, severe manifestations like intense local pain or signs of an acute allergic reaction are possible.

Official Safety Constraints

Category Details
Frequency Classification Formal frequency categories (e.g., common, rare) are not explicitly assigned to the primary adverse effects in the cited regulatory documents.
Safety Restriction Use is contraindicated in individuals with a known hypersensitivity or allergy to the active substance, Sodium Hypochlorite, or any of the product’s inactive components.
Special Populations Regulatory documents do not list specific safety notes for populations such as older adults or those with organ impairment, nor are time-related safety patterns explicitly stated.

The official safety information structures the risk understanding around the potential for localized reactions at the application site. The critical safety limitation defined in the label is the contraindication based on a known allergy to the active ingredient.

Overdose and Emergency Response

Overdose and When to Seek Help: Official Regulatory Information

The regulatory documentation for this topical solution defines the overdose profile primarily around the hazards of accidental ingestion (swallowing) of the liquid. Topical overuse is typically not expected to result in dangerous systemic exposure.

Overdose Scope Official Regulatory Statements
Documented Manifestations Symptoms following ingestion may include immediate burning sensation in the mouth and throat, abdominal pain, vomiting, and diarrhea.
Severe Outcomes Potential severe manifestations include corrosive damage to the gastrointestinal tract, pulmonary oedema, and systemic effects such as metabolic acidosis.
Population Notes Children are specifically noted in labeling as a population at risk for accidental ingestion.

Required Emergency Response

Official regulatory labeling explicitly mandates that immediate medical attention must be sought if the solution is accidentally swallowed. This urgent action is required due to the potential for caustic injury and severe systemic effects documented in overdose cases. It is mandated to contact a Poison Control Center or emergency medical services right away, and hospital monitoring and observation may be necessary.

Overdose Management

Overdose management is centered on providing symptomatic and supportive treatment. Regulatory information states that no specific antidote is formally known for Sodium Hypochlorite exposure. This structured approach ensures that the immediate need for emergency intervention is emphasized, adhering strictly to the official requirements and documented risks.

Therapeutic Uses of Amukine

What Amukine Treats: Main Uses and Benefits

This topical antiseptic preparation is commonly used for damaged skin and mucous membranes. The solution is applied across domains where additional symptomatic support is needed to address the risk of microbial contamination.

The solution is commonly used to help with various acute injuries, including minor cuts, abrasions, and first-degree burns, as well as for the symptomatic management of chronic dermal lesions and sores, such as skin ulcers. This application is relevant in situations where tissue damage creates the potential for microbial proliferation. The preparation may assist with managing the symptom clusters that can arise from infection risk, which supports the patient during difficult episodes by easing distress and contributes to improved day-to-day comfort. In contexts of chronic care or for vulnerable skin, the solution assists with maintaining cleanliness and helps address the symptom clusters linked to increased contamination. This contributes to easing the overall symptom load and supports general well-being during symptomatic phases.

Quick Fact: Relief for Contamination Risk
Supports the management of infection risk and assists with maintaining cleanliness in acute and chronic skin lesions.

Regulatory References

  1. DailyMed Label for Sodium Hypochlorite Solution

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Amukine — Official Regulatory Information

The eligibility profile for Amukine (Sodium Hypochlorite Topical Solution) is strictly defined by official regulatory labeling, which focuses primarily on hypersensitivity and the external route of administration.


Eligibility Scope

Category Official Regulatory Classification
Populations for whom use is allowed: General adult population for external application to skin and mucous membranes.
Populations for whom use is contraindicated: Individuals with known hypersensitivity to Sodium Hypochlorite or general sensitivity to chlorine products.
Age-related eligibility rules: Adults and Older Adults are eligible for standard topical use. Pediatric populations do not have an absolute minimum age restriction documented for external use.
Condition-specific eligibility rules: No restrictions are documented based on hepatic or renal impairment, consistent with the external topical route of administration.
Pregnancy and lactation eligibility status: Pregnancy: Use is conditional and permitted only when clearly needed. Lactation: Use is restricted, as it is officially unknown if the product passes into breast milk.
Eligibility-related restrictions: The product is strictly for external use only and must not be used in the eyes, ears, or nose.

Eligibility Classifications (High-Level)

Classification Type Official Regulatory Classification
Eligibility severity classification: Contraindicated (for hypersensitivity); Conditional Use (for pregnancy/lactation).
Regulatory basis: Based on the prescribing information for Sodium Hypochlorite Topical Solution.
Eligibility-context constraints: Strictly External use only for skin and mucous membranes.

Resulting Eligibility Structure

Official eligibility statements:

  • Use is contraindicated in patients with a history of hypersensitivity to the active ingredient or general chlorine sensitivity.
  • The medicine is strictly limited to external topical application and must not be used in the eyes, ears, or nose.
  • Eligibility during pregnancy is conditional, and the medicine should be used only when clearly needed.
  • Eligibility during lactation is restricted due to insufficient data on product transfer into breast milk.

Connection to the overall eligibility profile:

Regulatory documents define eligibility by establishing absolute non-eligibility based on hypersensitivity reactions and by restricting use to the defined external application site only. Use during physiological states like pregnancy and lactation is classified as conditional due to regulatory caution regarding potential systemic exposure or insufficient human data.

What should I know about interactions with other medicines?

Amukine, which contains the active ingredient sodium hypochlorite, is a topical antiseptic used for the disinfection of wounds, sores, and burns. Because its use is limited to external application on the skin and mucous membranes, the risk of systemic drug-to-drug interactions is considered unlikely.

However, Amukine can interact locally with other topical products, which may reduce its efficacy or lead to localized irritation. It is strongly advised to avoid the simultaneous or successive use of this antiseptic with other local treatments without thorough rinsing between applications.

️ Key Topical Interactions

Product Type Interaction Effect Guidance
Soaps and Detergents Chemical antagonism may neutralize the antiseptic action of Amukine. Rinse the area carefully after using soap and before applying Amukine.
Other Antiseptics Potential for antagonism (canceling each other's effects) or increased local irritation. Avoid combining with other antiseptic solutions.

Before using Amukine, inform your doctor or pharmacist of all other topical products, prescription or non-prescription, currently being used on the same area. The presence of organic materials, such as blood or serum, can also reduce the antiseptic activity of sodium hypochlorite, necessitating repeated applications as needed.

Mechanism of Action

How Amukine Works: Mechanistic Domains

Amukine, which contains Sodium Hypochlorite in a diluted aqueous solution, operates via a non-specific microbicidal mechanism that chemically destroys microorganisms rather than modulating specific human biological pathways.

Non-Specific Cellular Oxidation

The primary chemical action is mediated by the active chlorine species, primarily hypochlorous acid ( HOCl), which acts as a strong oxidizing agent. This process initiates widespread, indiscriminate chemical damage upon contact with microbial cell membranes and internal cellular components, leading to rapid loss of cellular integrity.

Macromolecule Destruction and Enzyme Inactivation

This mechanism focuses on targets within the microorganism, specifically the inactivation of critical proteins and enzymes and the modification of nucleic acids (DNA/RNA). The chemical reaction with these core biological molecules causes them to unfold and become non-functional, which halts metabolic activity and prevents genetic replication.

pH-Dependent Activity and Penetration

The pH of the solution critically dictates the balance between the highly reactive, uncharged HOCl and the less reactive, charged hypochlorite ion ( OCl^-). This specific chemical equilibrium drives the formation of the HOCl species, supporting the necessary cellular penetration required for the mechanism's execution.

Dosage and Administration Information

How to Use Amukine (Sodium Hypochlorite Solution)

Amukine is a topical antiseptic solution used for the disinfection and cleaning of damaged skin (e.g., wounds, sores, burns) and the external genitalia. Its active ingredient is Sodium Hypochlorite at concentrations typically ranging from 0.05% to 0.06% active chlorine.

Application Instructions

Amukine solution must be applied undiluted to the area being treated to ensure its effectiveness. Applications can be repeated as needed, typically up to six times per day for the 0.05% concentration, or not exceeding a maximum daily dose of 4.2 mL for the 0.06% concentration.

The solution can be applied using several methods:

Method Description Primary Use
Washing/Irrigation Pouring the solution directly over the area. Cleaning superficial wounds.
Soaked Compresses Applying a gauze or compress thoroughly soaked with the solution. Prolonged local disinfection.
Moistened Bandages Using the solution to dampen a dressing applied to the area. Disinfection of sensitive or confined areas.
Local Baths Immersing the affected area (e.g., fingers, feet) in the solution. Disinfection of extremities.

Important Precautions

  • External Use Only: This medication is strictly for external, topical application.
  • Avoid Prolonged Use: Do not use for prolonged treatments; consult a healthcare professional if no improvement is noted after a short period.
  • Interactions: Avoid using Amukine simultaneously with other topical antiseptics or soaps, as their effects may be reduced or cancelled out.
  • Storage: The solution is susceptible to microbial contamination once opened. Consult the product information for the specific shelf-life after opening (e.g., within six months).

Recent Clinical Evidence

Research Evidence / Overview of Studies for Topical Sodium Hypochlorite

Evidence for Use in Chronic and Hard-to-Heal Wounds

Research was evaluated in settings exploring how symptoms change over time, focusing on hard-to-heal wounds like venous or diabetic foot ulcers. Studies were observed in adult populations, primarily monitoring outcomes related to the microbial load and the total area of the wound. These studies explored measured changes in wound size or in the appearance of granulation tissue over defined time intervals. The findings describe patterns observed in the studies related to measurements of wound area and microbial counts. Systematic reviews describe comparisons between the solution and other compounds that were explored in trials, focusing on short-term outcomes.

Evidence is limited when it comes to long-term healing outcomes. Follow-up durations were limited, meaning there is limited information for long-term outcomes regarding whether measured changes persist after the study period concludes. Furthermore, evidence quality varies across studies, and many older studies used different formulations, which means the results apply only to the populations studied and specific preparations.

Evidence for Use in Skin Antisepsis and Microbial Reduction

This part of the overview will outline the types of comparative trials and foundational laboratory studies that have examined the solution's properties for reducing the bacterial count on skin and mucous membranes. The solution was studied for its properties as a broad-spectrum antiseptic, particularly for immediate skin decontamination. The research examined bacterial colony counts on the skin's surface and the time required to achieve a measured shift in microbial burden.

Laboratory research provides insight into short-term changes, showing patterns related to antimicrobial activity measurements. Comparative human trials reported measurements of immediate changes in bacterial counts on skin surfaces following application, relative to control solutions. The primary focus of this evidence is limited to the very short term, focusing on the immediate decontaminating effects.

What is Still Uncertain About the Research

Multiple limitations affect the overall evidence landscape for this solution. The evidence quality varies across studies, often due to small sample sizes or methodologies in older trials that introduce uncertainty. Comparative evidence is lacking for certain indications, meaning that while research describes patterns observed in trials, head-to-head data against all current standard-of-care treatments may be insufficient. Long-term effects are not fully established, and research is ongoing to provide deeper context regarding sustainable outcomes.

Key Studies & References

  1. Randomized controlled trial of sodium hypochlorite washes in adult atopic dermatitis
  2. National Drug Code (NDC) Directory: Sodium Hypochlorite Solution
  3. WHO Model List of Essential Medicines: Topical Antiseptics and Disinfectants

Frequently Asked Questions (FAQ)

Common questions about Amukine (FAQ)


Q: What specific types of germs or microbes does Amukine work against?

The active ingredient in Amukine, sodium hypochlorite, is described in official sources as having a broad-spectrum action. This means it is effective against a wide range of microorganisms, including different types of bacteria, viruses, fungi, and even bacterial spores.


Q: Is Amukine available for purchase without a doctor's prescription?

Regulatory databases designate products containing this concentration of sodium hypochlorite for topical antiseptic use as a HUMAN OTC DRUG. This classification means it is an Over-The-Counter drug and can be purchased without a prescription.


Q: How does the concentration of Amukine compare factually to the concentration of typical household bleach?

According to chemical data, Amukine is significantly more dilute than typical household bleach. Amukine contains 0.05% to 0.06% sodium hypochlorite, whereas household bleach is generally sold at concentrations ranging from approximately 3% to 9%.


Q: What is the difference between the 'antiseptic' and 'disinfectant' labels sometimes used for Amukine?

The medical distinction is that an antiseptic is formulated to kill or eliminate microorganisms on living tissues, such as the skin and mucous membranes. In contrast, a disinfectant is used to achieve the same result on inanimate objects and surfaces. Amukine is primarily used as an antiseptic.


Q: What should be done if an irritation or burning sensation from Amukine does not resolve quickly?

According to regulatory labels, redness, irritation, swelling, or pain that persists or increases should prompt discontinuation of the product. In such circumstances, seeking advice from a healthcare professional is noted.


Q: What are the potential effects of accidental swallowing of a small amount of Amukine solution?

The product is strictly for external use. Official regulatory information advises that if Amukine is accidentally swallowed, immediate contact with a Poison Control Center or medical emergency services is indicated.


Q: Can Amukine be safely used on both minor cuts and larger abrasions or burns?

Official product information indicates that Amukine is used for infections of the skin and tissues, including cuts, abrasions, and skin ulcers. While regulatory documents do not define a specific maximum size for the wound area, the instructions are directed towards application to the affected site.


Q: Are there restrictions on the total surface area of skin that Amukine can be applied to at once?

Official information indicates the product is for application to the affected area of skin. Although a specific maximum surface area is not stated, regulatory labels advise protecting the healthy skin surrounding the wound with an oil-based ointment to reduce potential irritation.


Q: What precautions must be taken if Amukine is used on a large open wound?

Regulatory documents recommend specific wound care precautions, such as protecting the intact skin around the wound with a moisture barrier ointment or skin sealant. Additionally, frequent application of the solution may be needed if the wound is highly exudative (highly draining).


Q: What specific properties make Amukine a suitable choice for treating sores and bedsores?

Official and supporting medical literature notes that the active ingredient, sodium hypochlorite, possesses a solvent action on dead cells. This property helps hasten the separation of dead tissue from living tissue, which is considered beneficial for managing chronic wounds like ulcers and sores.


Q: Is Amukine the same formulation as the widely known Dakin's solution?

Amukine and Dakin’s solution both rely on sodium hypochlorite as their core active ingredient. However, Dakin’s solution is a dilute hypochlorite solution that is typically buffered and is often prepared at a lower concentration for wound care than Amukine’s typical 0.05% to 0.06% concentration.


Q: Is Amukine used in a hospital setting, or is it only for home use?

The active ingredient, sodium hypochlorite, is a compound widely used in hospital and laboratory settings for general disinfection purposes. While regulatory labels focus on consumer use, the compound's history of use in professional contexts supports its general application as a germicide.


Q: Does Amukine contain any preservatives or excipients that could cause side effects?

Official regulatory labels list the inactive ingredients, also known as excipients, found in the product. These typically include Purified Water, Sodium Bicarbonate, and Sodium Hydroxide.


Q: Are there any special warnings about using Amukine under an occlusive (air-tight) dressing?

Official regulatory information confirms that the product may be used as the wetting agent for a wet-to-moist dressing. Specific warnings for use under a fully occlusive (air-tight) dressing beyond this method are not typically listed on the product label.


Q: Can Amukine cause any temporary or permanent change to the color of the skin?

Regulatory documents include a warning that the product May bleach clothing. While no specific warning is commonly listed regarding a permanent change to skin color, the warning about clothing is available.


Q: What clinical research exists regarding the use of Amukine in people who are pregnant?

The active ingredient is given an FDA Category C classification for use during pregnancy, meaning animal studies show potential adverse fetal effects, but adequate human studies are lacking. Use is noted to occur often in pregnancy and lactation due to the limited systemic absorption of the topical solution.


Q: Is there evidence indicating that Amukine is generally less irritating than certain other common topical antiseptics?

While regulatory documents do not offer a general comparison, a clinical trial examining preoperative antisepsis found that the ocular safety of the 0.06% solution was not statistically different from a 5% povidone iodine solution. The solution's formulation is described as non-irritating at its medicinal concentration.

How should Amukine be stored and disposed of?

Official Storage Requirements

Regulatory documents mandate specific conditions for storing Amukine (Sodium Hypochlorite Topical Solution) to maintain its potency. The product must be stored at room temperature and requires protection from light; containers should be kept in a dark location and tightly closed. The solution must not be frozen or exposed to high heat, as temperature extremes cause the product to lose strength.

Stability and Disposal

The product's stability is time-sensitive after opening. Opened containers or freshly prepared solutions must be discarded after 48 hours. Unopened bulk preparations should be discarded after 30 days from preparation. As a mandatory safety requirement, the product must be kept out of reach of children and pets. Single-use applicators and any remaining product must be discarded immediately after a single application, following general medicinal waste disposal practices.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Amukine found in:

A-Z Index: